FOXD3-AS1 suppresses the progression of non-small cell lung cancer by regulating miR-150/SRCIN1axis.

CONCLUSIONS: FOXD3-AS1 indirectly enhances the expression of SRCIN1 by targeting miR-150, thereby inhibiting NSCLC progression. PMID: 32924985 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32924985?dopt=Abstract

Source: Cancer Biomarkers - September 16, 2020 Category: Cancer & Oncology Tags: Cancer Biomark Source Type: research

More News: Cancer | Cancer & Oncology | Genetics | Lung Cancer | Non-Small Cell Lung Cancer